Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
WALTHAM, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4.24 | -20.7334963325 | 20.45 | 21.13 | 14.97 | 474779 | 18.21329057 | CS |
| 4 | -1.26 | -7.21236405266 | 17.47 | 24.975 | 14.97 | 279076 | 19.82249572 | CS |
| 12 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 26 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 52 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 156 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| 260 | -5.29 | -24.6046511628 | 21.5 | 29.3 | 14.97 | 321270 | 22.5700444 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
